Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMGN ImmunoGen > Detailed Quotes

IMGN ImmunoGen

4.480
-0.100-2.18%
Close 09/26 16:00 ET
4.4800.0000.00%
Post Mkt Price 09/26 16:02 ET
High
4.735
Open
4.560
Turnover
7.69M
Low
4.460
Pre Close
4.580
Volume
1.70M
Market Cap
988.79M
P/E(TTM)
Loss
52wk High
7.770
Shares
220.71M
P/E(Static)
Loss
52wk Low
3.095
Float Cap
768.06M
Bid/Ask %
33.33%
Historical High
45.500
Shs Float
171.44M
Volume Ratio
0.72
Historical Low
0.719
Dividend TTM
--
Div Yield TTM
--
P/B
3.96
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.99%
Amplitude
6.00%
Avg Price
4.532
Lot Size
1
Float Cap
768.06M
Bid/Ask %
33.33%
Historical High
45.500
Shs Float
171.44M
Volume Ratio
0.72
Historical Low
0.719
Dividend TTM
--
P/B
3.96
Dividend LFY
--
Turnover Ratio
0.99%
Amplitude
6.00%
Avg Price
4.532
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA.
CEO: Mr. Mark Joseph Enyedy
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...